Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase

Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase

There is currently a lack of effective drugs to treat people infected with SARS-CoV-2, the cause of the global COVID-19 pandemic. The SARS-CoV-2 Non-structural protein 13 (NSP13) has been identified as a target for anti-virals due to its high sequence conservation and essential role in viral replica...

Bibliografski detalji
Glavni autori:	Newman, JA, Douangamath, A, Yadzani, S, Yosaatmadja, Y, Aimon, A, Brandão-Neto, J, Dunnett, L, Gorrie-Stone, T, Skyner, R, Fearon, D, Schapira, M, von Delft, F, Gileadi, O
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2021

Slični predmeti

Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
od: Joseph A. Newman, i dr.
Izdano: (2021-08-01)

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
od: Schuller, M, i dr.
Izdano: (2021)

Achieving a good crystal system for crystallographic X-ray fragment screening
od: Collins, P, i dr.
Izdano: (2018)

Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development
od: Imprachim, N, i dr.
Izdano: (2022)

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
od: Alice Douangamath, i dr.
Izdano: (2020-10-01)

Fragmenstein: predicting protein–ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding–based methodology
od: Ferla, MP, i dr.
Izdano: (2025)

Duplex Unwinding Mechanism of Coronavirus MERS-CoV nsp13 Helicase
od: Wei Hao, i dr.
Izdano: (2024-12-01)

Novel Tetrazolium-Based Colorimetric Assay for Helicase nsp13 in SARS-CoV-2
od: Triet M. Pham, i dr.
Izdano: (2024-05-01)

Fragmenstein: predicting protein–ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding–based methodology
od: Matteo P. Ferla, i dr.
Izdano: (2025-01-01)

Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5.
od: Newman, J, i dr.
Izdano: (2017)

In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets
od: Federico Ricci, i dr.
Izdano: (2022-03-01)

A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance
od: Samantha L. Grimes, i dr.
Izdano: (2023-08-01)

Z-RNA and the Flipside of the SARS Nsp13 Helicase: Is There a Role for Flipons in Coronavirus-Induced Pathology?
od: Alan Herbert, i dr.
Izdano: (2022-06-01)

Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase
od: Law, Yee-Song, i dr.
Izdano: (2020)

Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex
od: Maria Kuzikov, i dr.
Izdano: (2024-05-01)

Characterisation of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification
od: Baddock, H, i dr.
Izdano: (2020)

Fragment libraries designed to be functionally diverse recover protein binding information more efficiently than standard structurally diverse libraries
od: Carbery, A, i dr.
Izdano: (2022)

Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase
od: Chuang Zhang, i dr.
Izdano: (2024-05-01)

Structure of the helicase core of Werner helicase, a key target in microsatellite instability cancers
od: Newman, JA, i dr.
Izdano: (2020)

Discovery and development strategies for SARS-CoV-2 NSP3 macrodomain inhibitors
od: Schuller, M, i dr.
Izdano: (2023)

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
od: Muhammad Usman Mirza, i dr.
Izdano: (2020-08-01)

Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
od: Matthew R Freidel, i dr.
Izdano: (2021-01-01)

SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
od: Sin-Yee Fung, i dr.
Izdano: (2022-03-01)

Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
od: Marion Schuller, i dr.
Izdano: (2023-02-01)

Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification
od: Baddock, HT, i dr.
Izdano: (2022)

Effective Binding Affinity of Inhibitor N-(3-(Carbamoylamino) Phenyl) Acetamide against the SARS-CoV-2 NSP13 Helicase
od: Rajneesh Prajapat, i dr.
Izdano: (2022-11-01)

Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main protease
od: Simon Bray, i dr.
Izdano: (2022-04-01)

Human RECQL5 Helicase; A Target Enabling Package
od: Gileadi, O
Izdano: (2018)

Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors
od: Mahmoud A. El Hassab, i dr.
Izdano: (2022-12-01)

Interdomain flexibility of Chikungunya virus nsP2 helicase-protease differentially influences viral RNA replication and infectivity
od: Law, Yee-Song, i dr.
Izdano: (2022)

Cellular RNA Helicase DDX1 Is Involved in Transmissible Gastroenteritis Virus nsp14-Induced Interferon-Beta Production
od: Yanrong Zhou, i dr.
Izdano: (2017-08-01)

Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting
od: Ali Khanifar, i dr.
Izdano: (2024-07-01)

SARS-CoV-2 helicase NSP13 hijacks the host protein EWSR1 to promote viral replication by enhancing RNA unwinding activity
od: Hongxiang Zeng, i dr.
Izdano: (2022-03-01)

Probing the structural basis of RecQ helicase function.
od: Vindigni, A, i dr.
Izdano: (2010)

Probing the structural basis of RecQ helicase function
od: Vindigni, A, i dr.
Izdano: (2010)

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
od: Chun-Kit Yuen, i dr.
Izdano: (2020-01-01)

Structure of the helicase domain of DNA polymerase theta reveals a possible role in the microhomology-mediated end-joining pathway
od: Newman, J, i dr.
Izdano: (2015)

The SNM1A DNA repair nuclease
od: Baddock, HT, i dr.
Izdano: (2020)

Designing more efficient compound libraries for crystallographic fragment screening
od: Carbery, A
Izdano: (2023)

Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B
od: Tamar Skaist Mehlman, i dr.
Izdano: (2023-03-01)